Curevac N.V. (NQ: CVAC )
3.265
+0.055
(+1.71%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 11, 2024
Add to My Watchlist
Headline News about Curevac N.V.
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
Via Benzinga
Exposures
COVID-19
Earnings Scheduled For November 12, 2024
November 12, 2024
Via Benzinga
Insights into CureVac's Upcoming Earnings
November 11, 2024
Via Benzinga
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
December 19, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|